# Platelet-Rich Plasma Injection Versus Hydrodissection in the Treatment of Carpal Tunnel Syndrome

> **NCT06368505** · NA · UNKNOWN · sponsor: **Osama Ahmed Elshafei** · enrollment: 64 (estimated)

## Conditions studied

- Carpal Tunnel Syndrome

## Interventions

- **OTHER:** ultrasound guided PRP injection
- **OTHER:** ultrasound guided hydrodissection

## Key facts

- **NCT ID:** NCT06368505
- **Lead sponsor:** Osama Ahmed Elshafei
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-16
- **Primary completion:** 2024-06-16
- **Final completion:** 2024-07-16
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06368505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06368505, "Platelet-Rich Plasma Injection Versus Hydrodissection in the Treatment of Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06368505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*